Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.

Clinical genitourinary cancer - 1 Feb 2017

Tosoian Jeffrey J, Gorin Michael A, Rowe Steven P, Andreas Darian, Szabo Zsolt, Pienta Kenneth J, Pomper Martin G, Lotan Tamara L, Ross Ashley E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Carcinoma, Neuroendocrine
Share to Lysine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Imaging

Share to Positron Emission Tomography Computed Tomography

Share to Retinoblastoma Binding Proteins

Share to Ubiquitin-Protein Ligases

Source

Open in PubMed Open full text

Identifiers

PMID: 27751686
DOI: 10.1016/j.clgc.2016.09.002
PMCID: PMC5572129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.PMID 27751686Read ↗

Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular CorrelatesSemantic proximity Read ↗

When PSMA Is Not Enough: The Diagnostic Blind Spots of PSMA PET/CT and the Added Value of [¹⁸F]FDG in High-Risk Prostate Cancer: Dual-Tracer Cohort StudySemantic proximity Read ↗

Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for <sup>18</sup>F-FDG Imaging of PSMA-Suppressed TumorsSemantic proximity Read ↗

Beyond PSMA: The essential complementary role of MRI in staging prostate cancer with Low-PSMA expression phenotypes.Semantic proximity Read ↗

Dual-Tracer 18 F-FDG and 68 Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy.Semantic proximity Read ↗

Dual-tracer PET/CT identifies an aggressive PSMA-negative/FDG-positive phenotype predicting early failure of radical prostatectomy in treatment-naive prostate cancer.Semantic proximity Read ↗

Patterns of disease detection using 18F-DCFPyL PET/CT imaging in men with biochemical recurrence post prostatectomy being considered for salvage radiotherapy: a prospective trialSemantic proximity Read ↗

CREBBP Mutation as a Culprit for Negative SSTR2 PET in Neuroendocrine Tumors.Semantic proximity Read ↗

PSMA expression on neovasculature of solid tumors.Semantic proximity Read ↗

Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancerSemantic proximity Read ↗

Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.Semantic proximity Read ↗

Image-Guided Fine-Needle Aspiration Cytology for BRCA Mutation Assessment of PSMA-Positive Lymph Node Metastases in a Patient With Metastatic Castration-Resistant Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.